Experion Holdings Ltd. is pleased to announce the launch of its premium brand, Citizen Stash, into Ontario where it will be available in stores and online in the coming weeks.
Tuesday, June 2, 2020 8:45 AM EDT
VANCOUVER, BC / ACCESSWIRE / June 2, 2020 / Experion Holdings Ltd. (the “Company” or “Experion”) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce the launch of its premium brand, Citizen Stash, into Ontario where it will be available in stores and online (ocs.ca) in the coming weeks.
The Company’s wholly-owned subsidiary, Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of top shelf cannabis, has signed an agreement with the Ontario Cannabis Store (“OCS”) to officially supply premium cannabis products to the province’s retail network. Ontario is the seventh Canadian province and territory with which Experion has announced distribution and is currently projected to have the largest number of cannabis retailers of any province. Approximately 450 cannabis stores applications were filed in March 2020 under Ontario’s new open-market process.
Mr. Jarrett Malnarich, Chief Executive Officer, commented “We are thrilled to announce our partnership with the OCS and look forward to supplying our high quality in-demand products to cannabis consumers in Ontario long-term. The province is another key milestone for Experion as we continue to build a best-in-class retail distribution network coast to coast for our premium cannabis products to solidify our position in Canada’s cannabis marketplace and take steps towards near-term profitability.”
About Experion Holdings Ltd.
Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.
Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.
Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31"
For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com
Disclosure
This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.
Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Experion Holdings Ltd.